All Clinical Trials
View all active clinical trials around the US.
Verified
Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults and Pediatrics
OPTIMIZED CORD BLOOD TRANSPLANT
Verified
Cord Blood Transplantation in Children and Young Adults With Hematologic Malignancies and Non-malignant Disorders
CORD BLOOD TRANSPLANTATION IN CHILDRENSparkCures Verified Accurate, up-to-date information. Learn more
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
CAR T IN PATIENTS WITH RENAL IMPAIRMENTAllogeneic Hematopoietic Stem Cell Transplant for Patients With Mutations in GATA2 or the MonoMAC Syndrome
ALLO STEM CELL TRANSPLANT FOR GATA2 MUTATIONSTwo Step Haplo With Radiation Conditioning
RADIATION-BASED REDUCED INTENSITY CONDITIONINGPhase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood ...
A/B TCD PERIPHERAL BLOOD STEM CELL TRANSPLANTATIONMT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosp...
ALLOGENEIC STEM CELL TRANSPLANTMaster Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials
MYELOMATCH MASTER PROTOCOLAlpha/Beta TCD HCT in Patients With Inherited BMF Disorders
T CELL RECEPTOR DEPLETION IN STEM CELL TRANSPLANTPhase II Clinical Trial of 2 Step ATG Combined With Tacrolimus and Mini Methotrexate for Prevention of Acut...
ATG DOSING FOR GVHD PREVENTIONA Phase II Randomized Controlled Trial Comparing GVHD-Reduction Strategies for Allogeneic Peripheral Blood ...
GRAFT VERSUS HOST DISEASE-REDUCTION STRATEGIESA Phase II Randomized Clinical Trial of Venetoclax Combined With FLAG IDA Induction and Consolidation Compa...
VENETOCLAX WITH INDUCTION & CONSOLIDATIONPilot Study of FLAG-Ida Followed Immediately by Reduced-Intensity Allogeneic HCT for Adults Age 60 and Olde...
COMBINATION CHEMOTHERAPY PRE-ALLOGENEIC SCTABBA CORD: Double Umbilical Cord Blood Transplants With Abatacept for Graft Versus Host Disease Prophylaxis
ABATACEPT IN DOUBLE CORD BLOOD UNIT TRANSPLANTUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREPPersonalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYDART: Phase II Study of Dasatinib and Quercetin in Patients With Relapsed, Refractory Multiple Myeloma Rece...
DASATINIB & QUERCETIN WITH CAR-T CELL THERAPYMyeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANTA Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly D...
GEMTUZUMAB AS PART OF CHEMOTHERAPYVenetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
VENETOCLAX AS PART OF PRE-TRANSPLANT CHEMOTHERAPYPhase I/II Study Using Prophylactic Donor Lymphocyte Infusion Early Post-Transplant After Allogeneic Hemato...
DONOR LYMPHOCYTE INFUSION POST TRANSPLANTSequential Decitabine in Combination With FLAG-Ida Followed Immediately by Reduced-Intensity Conditioning (...
DECITABINE COMBINATION THERAPY PRE-ASCTA Phase 1 Study of GRN163L (Imetelstat) in Combination With Fludarabine and Cytarabine for Patients With Ac...
IMETELSTAT COMBINATION THERAPYAn Open-label, Non-randomized, Prospective Trial to Evaluate the Effect of Renal Function Impairment and Ra...
TREOSULFAN AND FLUDARABINE PRE-TRANSPLANTPhase I Study of Escalating Doses of 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody Added to the Cond...
RADIATION-BASED DARATUMUMABPhase I Study of Escalating Doses of Total Marrow and Lymphoid Irradiation (TMLI) Combined With Fludarabine...
TOTAL MARROW AND LYMPHOID IRRADIATIONA Phase I Study of Intensity Modulated Total Marrow Irradiation (IMTMI) in Addition to Fludarabine/Melphala...
INTENSITY MODULATED TOTAL MARROW IRRADIATION²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINEPhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymp...
CORD BLOOD-DERIVED NK CELLSA Phase 1b/2 Study of the BCL-2 Inhibitor Venetoclax in Combination With Standard Intensive AML Induction/C...
VENETOCLAX W/ COMBINATION CHEMOTHERAPYA Pilot/Phase 1 Study of Immunosuppression-free Regulatory T-cell Graft-engineered Haploidentical Hematopoi...
IS-FREE TREG STEM CELL TRANSPLANTUmbilical Cord Blood Transplantation From Unrelated Donors
UMBILICAL CORD BLOOD TRANSPLANTATIONFeasibility Study of CD34 Selection for GVHD Prophylaxis Using the Automated CliniMACS
GVHD PREVENTION USING CLINIMACSPhase 1 Trial of Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allo...
THIOTEPA-BASED CONDITIONING PRE-ALLO SCTA Phase 1b Clinical Trial of CRISPR Delivered Anti-BCMA Chimeric Antigen Receptor T Cells for Treatment of ...
CRISPR DELIVERED ANTI-BCMA CAR-TPeri-Hematopoietic Cell Transplantation Ruxolitinib in Patients With Myelofibrosis and Myelodysplastic Synd...
RUXOLITINIB DURING STEM CELL TRANSPLANTMT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfa...
REDUCED INTENSITY CONDITIONING TREOSULFAN
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
CAR T IN PATIENTS WITH RENAL IMPAIRMENT²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
CAR T IN PATIENTS WITH RENAL IMPAIRMENTUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREPPersonalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYMyeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANTPhase I/II Study Using Prophylactic Donor Lymphocyte Infusion Early Post-Transplant After Allogeneic Hemato...
DONOR LYMPHOCYTE INFUSION POST TRANSPLANT²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy ...
CAR T IN PATIENTS WITH RENAL IMPAIRMENTUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
UCB TRANSPLANT WITH MYELOABLATIVE PREPPersonalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelody...
PERSONALIZED NATURAL KILLER CELL THERAPYDART: Phase II Study of Dasatinib and Quercetin in Patients With Relapsed, Refractory Multiple Myeloma Rece...
DASATINIB & QUERCETIN WITH CAR-T CELL THERAPYMyeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...
MYELOABLATIVE ALLO STEM CELL TRANSPLANTPhase I/II Study Using Prophylactic Donor Lymphocyte Infusion Early Post-Transplant After Allogeneic Hemato...
DONOR LYMPHOCYTE INFUSION POST TRANSPLANT²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...
²¹¹AT-OKT10-B10 WITH FLUDARABINE
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials